Table 4 CBCL profile of DSM-5 scales of studied group
Profile of DSM-5 scales | Children who had not COVID-19 (n=108) | Children who had COVID-19 (N=30) | Total participants (N=138) | Chi-square value | P-value | |
|---|---|---|---|---|---|---|
Affective problems | Normal | 94 (87%) | 26 (86.7%) | 120 (87%) | 2.6 | 0.27 |
Borderline | 6 (5.6%) | 0 (0%) | 6 (4.3%) | |||
Clinical rating | 8 (7.4%) | 4 (13.3%) | 12 (8.7%) | |||
Anxiety problems | Normal | 88 (81.5%) | 20 (66.7%) | 108 (78.3%) | 3.37 | 0.18 |
Borderline | 10 (9.3%) | 6 (20%) | 16 (11.6%) | |||
Clinical rating | 10 (9.3%) | 4 (13.3%) | 14 (10.1%) | |||
Pervasive developmental problems | Normal | 78 (72.2%) | 22 (73.3%) | 100 (72.5%) | 1.2 | 0.54 |
Borderline | 14 (13%) | 2 (6.7%) | 16 (11.6%) | |||
Clinical rating | 16 (14.8%) | 6 (20%) | 22 (15.9%) | |||
Attention deficit /hyperactivity problems | Normal | 102 (94.4%) | 30 (100%) | 132 (95.7%) | 1.7 | 0.41 |
Borderline | 4 (3.7%) | 0 (0%) | 4 (2.9%) | |||
Clinical rating | 2 (1.9%) | 0 (0%) | 2 (1.4%) | |||
Oppositional defiant problems | Normal | 100 (92.6%) | 24 (80%) | 124 (89.9%) | 7.58 | 0.02* |
Borderline | 2 (1.9%) | 4 (13.3%) | 6 (4.3%) | |||
Clinical rating | 6 (5.6%) | 2 (6.7%) | 8 (5.8%) | |||